Navigation Links
Outcomes Vary for Prostate Cancer Patients Choosing Surgery; Overall, No Treatment Proven Superior
Date:2/4/2008

tly to expanded use of the Prostate Specific Antigen (PSA) blood test. But the risk of dying of prostate cancer remains about 3 percent. Therefore, considerable overdetection and overtreatment may exist. The U.S. Preventive Services Task Force, a panel of outside experts convened by AHRQ that makes independent evidence-based recommendations, maintains there is insufficient evidence to recommend for or against PSA testing for routine prostate cancer screening. PSA tests can detect early-stage cancer when it is potentially most treatable but also lead to frequent false-positive results and identification of prostate cancers unlikely to cause harm.

AHRQ's new report, based on a review of 592 published articles, compared eight prostate cancer strategies: complete surgical removal of prostate and related tissue; minimally invasive surgery to remove the prostate; external radiation; radioactive implants; destruction of cancer cells through rapid freezing and thawing; removal of testicles or hormone therapy; high-intensity ultrasound; and no immediate treatment, also known as "watchful waiting."

The report, compiled by AHRQ's Minnesota Evidence-based Practice Center, is intended to provide unbiased, evidence-based information so that patients, clinicians and others can make the best treatment decisions possible. Among its conclusions:

-- Not enough scientific evidence exists to identify any prostate cancer treatment as most effective for all men, especially those whose cancers were found by PSA testing. However, more than 90 percent of patients reported they would make the same treatment decision again, regardless of the treatment they received.

-- All treatment options cause health problems, primarily urinary incontinence, bowel problems and erectile dysfunction. The chances of bowel problems or sexual dysfunction are similar for surgery and external radiation. Leaking of urine is at least six times more likely among surgery patients th
'/>"/>

SOURCE Agency for Healthcare Research & Quality
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
2. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
3. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
4. Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
5. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
6. Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
7. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
8. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
9. Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... PAREXEL International Corporation (NASDAQ: PRXL ) announced today that ... Monday, May 18, 2015, in New York City.  Ingo ... be making a presentation on PAREXEL and discussing business developments ... the presentation will be available through the "Investors" section of ... portion of the main page, and a replay of the ...
(Date:5/4/2015)... May 4, 2015 PharmaEngine, Inc. (TWO:4162) ... Inc. (NASDAQ: MACK ) with its sublicensing ... jointly announced that Baxter has submitted a marketing ... (EMA) for MM-398 (irinotecan liposome injection), also known ... the pancreas who have been previously treated with ...
(Date:5/4/2015)... CRANBURY, N.J. , May 4, 2015 /PRNewswire/ ... and commercializing monoclonal antibody (mAb) biosimilars, has completed ... facility at its headquarters in Cranbury, ... Cranbury facility is designed to ... flexible manufacturing at commercial scale.  Through the use ...
Breaking Medicine Technology:PAREXEL International to Present at UBS Healthcare Conference 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 3
(Date:5/4/2015)... (PRWEB) May 04, 2015 In May of ... took his own life. In the wake of this tragedy, ... Silent, an organization that exposes the grim reality of bullying ... a platform for Kirk and Laura to share their story ... tragedy from happening to another family — a mission that ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 The U.S. ... baby boomers join the ranks of senior citizens (1) ... on an already over-burdened healthcare system. Additionally, as older ... to replace them. Per the U.S. Census Bureau, the ... to increase 75% by 2050 while those 25 to ...
(Date:5/4/2015)... NY (PRWEB) May 04, 2015 Ticket Down ... 2015 International Champions Cup (ICC) . While the World ... and is held every four years, the International Champions Cup ... the tournament saw the all-time attendance record for soccer in ... from the Big House at the University of Michigan. This ...
(Date:5/4/2015)... May 04, 2015 EyeCRO LLC and ... to facilitate development of NM108, a first-in-class small molecule ... to blindness, including Diabetic Retinopathy. The collaboration grants ... by EyeCRO, which can deliver drugs to the front ... , Under the terms of the agreement, EyeCRO ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Ticket Down is ... the John Paul Jones Arena in Charlottesville, VA. ... history of the music business and this beloved performer continues ... McCartney, the former member of two legendary groups: Wings and ... the music business since 2013 on the “Out There” tour ...
Breaking Medicine News(10 mins):Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 2Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 4Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2
... ... Station in support of the Novartis and IAFF STOP•DROP•CONTROL high blood pressure awareness and ... , ... (PRWEB) June 4, 2009 -- Lifeclinic International, Inc. , the world,s leading manufacturer ...
... (Nasdaq: HRLY ) announced today that its GMI ... approximately $4 million to provide various complex microwave switch assemblies ... an existing customer and program. The hardware will be used ... Herley Industries, Inc. acquired Eyal Microwave Industries, ("EMI") last year ...
... signs of human-like mirth, researchers say , THURSDAY, June 4 ... cast of Saturday Night Live , but they sure ... Marina Davila Ross, a primatologist at the University of Portsmouth ... three human babies to see how they would respond. While ...
... as promised, report,s authors say , THURSDAY, June 4 ... contributed to nearly two-thirds of all bankruptcies in the ... 2001, new research has found. , Since the data ... current economic downturn, it,s likely that the current rate ...
... Los Angeles, London, New Delhi, Singapore and Washington DC ... flagship medical journal Palliative Medicine is to ... Medicine. Formed in 1986, The Association for Palliative ... association of doctors who work in hospices and specialist ...
... of Loyola University Health System, who is studying treatment ... a prestigious Amgen Foundation Fellowship grant. Go, a ... Stiff, director of Loyola,s Cardinal Bernardin Cancer Center. Stiff ... blood transplants grown from cord blood cells outside the ...
Cached Medicine News:Health News:Lifeclinic Supports the Novartis and International Association of Fire Fighters Campaign Against Hypertension 2Health News:Lifeclinic Supports the Novartis and International Association of Fire Fighters Campaign Against Hypertension 3Health News:Herley's Israeli Subsidiary, GMI Eyal, is Selected to Provide Complex Microwave Switch Assemblies for a U.S. Customer 2Health News:Apes Love a Good Laugh, Too 2Health News:Apes Love a Good Laugh, Too 3Health News:Medical Bills Driving Most Middle-Class Bankruptcies 2Health News:Medical Bills Driving Most Middle-Class Bankruptcies 3
Inquire...
... • V-shaped bottom allows easy ... or 5 per bag ,• Corner ... Pipettor Solution Basin designed for 4, 8, ... V-shaped bottom permits withdrawal of practically all ...
... Calibration Software monitors and documents the accuracy ... entire operating life. This new program was ... from gravimetric or photometric pipette tests. It ... types from various manufacturers and other liquid ...
Reservoir, Low Profile, Single Well, Flat Bottom, 90mL Available Sterile...
Medicine Products: